Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diarrhea and vaccines: current developments].

P Landry1

  • 1Médecin associé, PMU, Lausanne et Neuchatel. pierrelandry@swissonline.ch

Revue Medicale Suisse
|June 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GW170817: Measurements of Neutron Star Radii and Equation of State.

Physical review letters·2018
Same author

[Quadrivalent meningococcal conjugate vaccine].

Revue medicale suisse·2011
Same author

[Tuberculosis detection and immunization of long-term travellers].

Revue medicale suisse·2009
Same author

[Security and travel].

Revue medicale suisse·2008
Same author

[Immunization against yellow fever].

Revue medicale suisse·2007
Same author

Evaluation of an inference-based approach to treating obsessive-compulsive disorder.

Cognitive behaviour therapy·2005
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Diarrhoea remains a significant health issue globally, particularly for travelers and children. While some vaccines exist, their efficacy is limited, and new options are costly or under development.

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Public Health

Context:

  • Diarrhoea poses a major global health challenge, affecting travelers, developing populations, and children.
  • Existing vaccines, like the cholera vaccine, offer limited cross-protection against common diarrheal pathogens such as enterotoxigenic E. coli (ETEC).
  • Rotavirus vaccines primarily target infant diarrhoea, with minimal impact on traveler's diarrhoea.

Purpose:

  • To review the current landscape of diarrhoeal diseases, available vaccines, and emerging vaccine candidates.
  • To highlight the limitations of current prophylactic measures against traveller's diarrhoea and other forms of infectious diarrhoea.
  • To discuss the challenges in developing and deploying cost-effective diarrhoeal disease vaccines for vulnerable populations.

Summary:

Related Experiment Videos

  • The cholera vaccine provides some protection against ETEC but shows only 23% efficacy against all-cause traveler's diarrhoea.
  • New vaccines under development show promise in efficacy and tolerability but are currently too expensive for resource-limited settings.
  • The live oral Ty21a vaccine is still used for specific indications but has suboptimal efficacy, with a new oral vaccine in development.

Impact:

  • Identifies critical unmet needs in diarrhoeal disease prevention, especially for travelers and in developing countries.
  • Underscores the economic barriers to accessing advanced vaccine technologies in regions where they are most needed.
  • Highlights the ongoing research and development efforts to create more effective and accessible diarrhoeal disease vaccines.